| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pasteurellaceae Infections | D016871 | 2 associated lipids |
| Dental Pulp Calcification | D003784 | 2 associated lipids |
| Bone Diseases, Developmental | D001848 | 2 associated lipids |
| Bone Cysts, Aneurysmal | D017824 | 2 associated lipids |
| Actinomycosis | D000196 | 2 associated lipids |
| Fractures, Stress | D015775 | 2 associated lipids |
| Osteosclerosis | D010026 | 2 associated lipids |
| Carcinoma, Neuroendocrine | D018278 | 2 associated lipids |
| Osteophyte | D054850 | 2 associated lipids |
| Pericardial Effusion | D010490 | 2 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Shea MK et al. | Vitamin K supplementation and progression of coronary artery calcium in older men and women. | 2009 | Am. J. Clin. Nutr. | pmid:19386744 |
| Sheng ZF et al. | Zoledronate reverses mandibular bone loss in osteoprotegerin-deficient mice. | 2009 | Osteoporos Int | pmid:18496637 |
| Guañabens N et al. | High osteoprotegerin serum levels in primary biliary cirrhosis are associated with disease severity but not with the mRNA gene expression in liver tissue. | 2009 | J. Bone Miner. Metab. | pmid:19229472 |
| Sun J et al. | Proliferation and gene expression of osteoblasts cultured in DMEM containing the ionic products of dicalcium silicate coating. | 2009 | Biomed. Pharmacother. | pmid:19231130 |
| West SL et al. | The effect of exercise and estrogen on osteoprotegerin in premenopausal women. | 2009 | Bone | pmid:18929691 |
| Tada T et al. | Oral squamous cell carcinoma cells modulate osteoclast function by RANKL-dependent and -independent mechanisms. | 2009 | Cancer Lett. | pmid:18930344 |
| Wasilewska A et al. | Serum osteoprotegrin (OPG) and receptor activator of nuclear factor kappaB (RANKL) in healthy children and adolescents. | 2009 | J. Pediatr. Endocrinol. Metab. | pmid:20333868 |
| Moran CS et al. | Interaction between angiotensin II, osteoprotegerin, and peroxisome proliferator-activated receptor-gamma in abdominal aortic aneurysm. | 2009 | J. Vasc. Res. | pmid:18931513 |
| Flint J et al. | Relationships between osteoprotegerin (OPG), receptor activator of nuclear factor kappaB ligand (RANKL), and growth hormone (GH) secretory status in short children. | 2009 | J. Pediatr. Endocrinol. Metab. | pmid:20333869 |
| Schofer MD et al. | Influence of nanofibers on the growth and osteogenic differentiation of stem cells: a comparison of biological collagen nanofibers and synthetic PLLA fibers. | 2009 | J Mater Sci Mater Med | pmid:18987945 |
| Ogino Y et al. | Platelet-rich plasma suppresses osteoclastogenesis by promoting the secretion of osteoprotegerin. | 2009 | J. Periodont. Res. | pmid:18681933 |
| Xu M et al. | Low-intensity pulsed laser irradiation affects RANKL and OPG mRNA expression in rat calvarial cells. | 2009 | Photomed Laser Surg | pmid:18800943 |
| Gu JH et al. | Effects of RANKL, osteoprotegerin, calcium and phosphorus on survival and activation of Muscovy duck osteoclasts in vitro. | 2009 | Vet. J. | pmid:18682334 |
| Nishiura R et al. | Elevated osteoprotegerin levels predict cardiovascular events in new hemodialysis patients. | 2009 | Am. J. Nephrol. | pmid:18802328 |
| Gürkan A et al. | Therapeutic efficacy of vasoactive intestinal peptide in escherichia coli lipopolysaccharide-induced experimental periodontitis in rats. | 2009 | J. Periodontol. | pmid:19792856 |
| Spencer AY and Lallier TE | Mechanical tension alters semaphorin expression in the periodontium. | 2009 | J. Periodontol. | pmid:19792857 |
| Greiner S et al. | Cocultures of osteoblasts and osteoclasts are influenced by local application of zoledronic acid incorporated in a poly(D,L-lactide) implant coating. | 2009 | J Biomed Mater Res A | pmid:18980195 |
| Harinarayan CV | Crohn's disease & osteoimmunology--is vitamin D the cross-talk co-ordinator? | 2009 | Indian J. Med. Res. | pmid:19797805 |
| Katopodis H et al. | MG-63 osteoblast-like cells enhance the osteoprotegerin expression of PC-3 prostate cancer cells. | 2009 | Anticancer Res. | pmid:19846944 |
| Trombone AP et al. | Experimental periodontitis in mice selected for maximal or minimal inflammatory reactions: increased inflammatory immune responsiveness drives increased alveolar bone loss without enhancing the control of periodontal infection. | 2009 | J. Periodont. Res. | pmid:18973535 |
| Sanchez C et al. | Mechanical loading highly increases IL-6 production and decreases OPG expression by osteoblasts. | 2009 | Osteoarthr. Cartil. | pmid:18974013 |
| Chanda D et al. | Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in prostate cancer bone metastasis. | 2009 | Clin. Cancer Res. | pmid:19920103 |
| Hozumi A et al. | Bone marrow adipocytes support dexamethasone-induced osteoclast differentiation. | 2009 | Biochem. Biophys. Res. Commun. | pmid:19324007 |
| Kaunitz AM et al. | Postmenopausal osteoporosis: fracture risk and prevention. | 2009 | J Fam Pract | pmid:19891943 |
| Semb AG et al. | Osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand and risk for coronary events: a nested case-control approach in the prospective EPIC-Norfolk population study 1993-2003. | 2009 | Arterioscler. Thromb. Vasc. Biol. | pmid:19325145 |
| Panizo S et al. | RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway. | 2009 | Circ. Res. | pmid:19325147 |
| Baud'huin M et al. | Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survival. | 2009 | J. Biol. Chem. | pmid:19758994 |
| Rifas L and Weitzmann MN | A novel T cell cytokine, secreted osteoclastogenic factor of activated T cells, induces osteoclast formation in a RANKL-independent manner. | 2009 | Arthritis Rheum. | pmid:19877052 |
| Bargnoux AS et al. | Evolution of coronary artery calcifications following kidney transplantation: relationship with osteoprotegerin levels. | 2009 | Am. J. Transplant. | pmid:19775319 |
| Dalle Carbonare L et al. | Circulating mesenchymal stem cells with abnormal osteogenic differentiation in patients with osteoporosis. | 2009 | Arthritis Rheum. | pmid:19877060 |
| Krajewski AC et al. | Influence of lipopolysaccharide and interleukin-6 on RANKL and OPG expression and release in human periodontal ligament cells. | 2009 | APMIS | pmid:19775343 |
| Hamed AA and Fayad JN | Presence of otosclerosis and paget lesions in the same temporal bone. | 2009 | Otol. Neurotol. | pmid:19779387 |
| Golledge J et al. | A single-nucleotide polymorphism in the gene encoding osteoprotegerin is associated with diastolic blood pressure in older men. | 2009 | Am. J. Hypertens. | pmid:19779468 |
| Schett G et al. | Tumor necrosis factor alpha and RANKL blockade cannot halt bony spur formation in experimental inflammatory arthritis. | 2009 | Arthritis Rheum. | pmid:19714640 |
| Kim CH et al. | Effects of high frequency loading on RANKL and OPG mRNA expression in ST-2 murine stromal cells. | 2009 | BMC Musculoskelet Disord | pmid:19728893 |
| Cozzolino M | Emerging roles for osteoprotegerin and receptor activator of nuclear factor-kappaB in the vascular system. | 2009 | Blood Purif. | pmid:19729903 |
| Anandarajah AP and Schwarz EM | Bone loss in the spondyloarthropathies: role of osteoclast, RANKL, RANK and OPG in the spondyloarthropathies. | 2009 | Adv. Exp. Med. Biol. | pmid:19731622 |
| Ryser MD et al. | Mathematical modeling of spatio-temporal dynamics of a single bone multicellular unit. | 2009 | J. Bone Miner. Res. | pmid:19063683 |
| Kadow-Romacker A et al. | Effect of mechanical stimulation on osteoblast- and osteoclast-like cells in vitro. | 2009 | Cells Tissues Organs (Print) | pmid:19033679 |
| Rauner M et al. | The HLA-B27 transgenic rat, a model of spondyloarthritis, has decreased bone mineral density and increased RANKL to osteoprotegerin mRNA ratio. | 2009 | J. Rheumatol. | pmid:19040304 |
| Buijs JT et al. | Inhibition of bone resorption and growth of breast cancer in the bone microenvironment. | 2009 | Bone | pmid:19041433 |
| Giner M et al. | RANKL/OPG in primary cultures of osteoblasts from post-menopausal women. Differences between osteoporotic hip fractures and osteoarthritis. | 2009 | J. Steroid Biochem. Mol. Biol. | pmid:19073256 |
| Zauli G et al. | Role of full-length osteoprotegerin in tumor cell biology. | 2009 | Cell. Mol. Life Sci. | pmid:19011755 |
| Kostenuik PJ et al. | Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKL. | 2009 | J. Bone Miner. Res. | pmid:19016581 |
| Lee JS et al. | Changes in serum levels of receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, IL-6 and TNF-alpha in patients with a concomitant head injury and fracture. | 2009 | Arch Orthop Trauma Surg | pmid:18427820 |
| Turk N et al. | Proinflammatory cytokines and receptor activator of nuclear factor kappaB-ligand/osteoprotegerin associated with bone deterioration in patients with Crohn's disease. | 2009 | Eur J Gastroenterol Hepatol | pmid:19098682 |
| McGonigle JS et al. | Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function. | 2009 | Angiogenesis | pmid:19105036 |
| Kwok SK et al. | Circulating osteoprotegerin levels are elevated and correlated with antiphospholipid antibodies in patients with systemic lupus erythematosus. | 2009 | Lupus | pmid:19151114 |
| Ren W et al. | Effect of oral erythromycin therapy in patients with aseptic loosening of joint prostheses. | 2009 | Bone | pmid:19154802 |
| Chiba Y et al. | Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women. | 2009 | Gerontology | pmid:19158438 |
| Sims TL et al. | Neural progenitor cell-mediated delivery of osteoprotegerin limits disease progression in a preclinical model of neuroblastoma bone metastasis. | 2009 | J. Pediatr. Surg. | pmid:19159744 |
| Madarász E et al. | Osteoprotegerin levels in women with prior gestational diabetes mellitus. | 2009 | Diabetes Care | pmid:19114622 |
| Yun HJ et al. | Adrenomedullin inhibits MAPK pathway-dependent rheumatoid synovial fibroblast-mediated osteoclastogenesis by IL-1 and TNF-alpha. | 2009 | Rheumatol. Int. | pmid:19116717 |
| Morena M et al. | A cut-off value of plasma osteoprotegerin level may predict the presence of coronary artery calcifications in chronic kidney disease patients. | 2009 | Nephrol. Dial. Transplant. | pmid:19574342 |
| Schnabel RB et al. | Relation of multiple inflammatory biomarkers to incident atrial fibrillation. | 2009 | Am. J. Cardiol. | pmid:19576326 |
| Geusens P | Emerging treatments for postmenopausal osteoporosis - focus on denosumab. | 2009 | Clin Interv Aging | pmid:19554095 |
| Sampaio MS et al. | Expression of eight genes of nuclear factor-kappa B pathway in multiple myeloma using bone marrow aspirates obtained at diagnosis. | 2009 | Histol. Histopathol. | pmid:19554506 |
| Booij-Vrieling HE et al. | Inflammatory cytokines and the nuclear vitamin D receptor are implicated in the pathophysiology of dental resorptive lesions in cats. | 2009 | Vet. Immunol. Immunopathol. | pmid:19556012 |
| Anastasilakis AD et al. | RANKL inhibition for the management of patients with benign metabolic bone disorders. | 2009 | Expert Opin Investig Drugs | pmid:19558335 |
| Yongchaitrakul T et al. | Osteoprotegerin induces osteopontin via syndecan-1 and phosphoinositol 3-kinase/Akt in human periodontal ligament cells. | 2009 | J. Periodont. Res. | pmid:19602124 |
| Alonso V et al. | Phytoestrogen modulation of bone-related cytokines and its impact on cell viability in human prostate cancer cells. | 2009 | Life Sci. | pmid:19632246 |
| Sauer AV et al. | ADA-deficient SCID is associated with a specific microenvironment and bone phenotype characterized by RANKL/OPG imbalance and osteoblast insufficiency. | 2009 | Blood | pmid:19633200 |
| Narducci P et al. | Interaction of human recombinant tumor necrosis factor-related apoptosis-inducing ligand and osteoprotegerin could contribute to enhancement of the erosive processes induced by human synovial cells. | 2009 | J. Rheumatol. | pmid:19671825 |
| Patiño-GarcÃa A et al. | Profiling of chemonaive osteosarcoma and paired-normal cells identifies EBF2 as a mediator of osteoprotegerin inhibition to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. | 2009 | Clin. Cancer Res. | pmid:19671856 |
| Eleftheriadis T et al. | The effect of paricalcitol on osteoprotegerin production by human peripheral blood mononuclear cells. | 2009 | J. Rheumatol. | pmid:19342729 |
| Spahni AI et al. | Immunohistochemical localization of RANK, RANKL and OPG in healthy and arthritic canine elbow joints. | 2009 | Vet Surg | pmid:19674422 |
| Mesquita M et al. | Plasma osteoprotegerin is an independent risk factor for mortality and an early biomarker of coronary vascular calcification in chronic kidney disease. | 2009 | Clin. Chem. Lab. Med. | pmid:19676147 |
| Kiani AN et al. | Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis. | 2009 | J. Rheumatol. | pmid:19648301 |
| Lappin DF et al. | Markers of bone destruction and formation and periodontitis in type 1 diabetes mellitus. | 2009 | J. Clin. Periodontol. | pmid:19624408 |
| Yokoyama M et al. | Dynamic changes in bone metabolism in the rat temporomandibular joint after molar extraction using bone scintigraphy. | 2009 | Eur. J. Oral Sci. | pmid:19627347 |
| Neves JS et al. | Immunolocalization of CSF-1, RANKL and OPG in the enamel-related periodontium of the rat incisor and their implications for alveolar bone remodeling. | 2009 | Arch. Oral Biol. | pmid:19419711 |
| Gasowska K et al. | The influence of unfractionated and low-molecular weight heparins on the properties of human umbilical vein endothelial cells (HUVEC). | 2009 | Folia Histochem. Cytobiol. | pmid:19419932 |
| Ali Z et al. | Association of serum osteoprotegerin with ankle-brachial index and urine albumin: creatinine ratio in African-Americans and non-Hispanic whites. | 2009 | Atherosclerosis | pmid:19423112 |
| Alexander MY | RANKL links arterial calcification with osteolysis. | 2009 | Circ. Res. | pmid:19423860 |
| Nakamura M et al. | [Osteoclastogenesis and bone resorption]. | 2009 | Nippon Rinsho | pmid:19432105 |
| Masuda H and Tanaka S | [Drugs under development for osteoporosis ]. | 2009 | Nippon Rinsho | pmid:19432120 |
| Korostishevsky M et al. | Anthropometric and bone-related biochemical factors are associated with different haplotypes of ANKH locus. | 2008 Sep-Oct | Ann. Hum. Biol. | pmid:18821330 |
| Spelling P et al. | Osteoprotegerin/RANKL system imbalance in active polyarticular-onset juvenile idiopathic arthritis: a bone damage biomarker? | 2008 Nov-Dec | Scand. J. Rheumatol. | pmid:18802807 |
| Reddi D et al. | Porphyromonas gingivalis regulates the RANKL-OPG system in bone marrow stromal cells. | 2008 Nov-Dec | Microbes Infect. | pmid:18789397 |
| Ainola M et al. | Imbalanced expression of RANKL and osteoprotegerin mRNA in pannus tissue of rheumatoid arthritis. | 2008 Mar-Apr | Clin. Exp. Rheumatol. | pmid:18565244 |
| Kwan Tat S et al. | The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells. | 2008 Mar-Apr | Clin. Exp. Rheumatol. | pmid:18565252 |
| Prezelj J et al. | Cathepsin K predicts femoral neck bone mineral density change in nonosteoporotic peri- and early postmenopausal women. | 2008 Mar-Apr | Menopause | pmid:17882010 |
| Kim JG et al. | Changes in the serum levels of osteoprotegerin and soluble receptor activator for nuclear factor kappaB ligand after estrogen-progestogen therapy and their relationships with changes in bone mass in postmenopausal women. | 2008 Mar-Apr | Menopause | pmid:17925661 |
| Ciacli C et al. | [Bone turnover markers evaluation in psoriatic arthritis]. | 2008 Jul-Sep | Rev Med Chir Soc Med Nat Iasi | pmid:20201244 |
| Sennels H et al. | Circulating levels of osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor-kappa B ligand, and high-sensitivity C-reactive protein in patients with active rheumatoid arthritis randomized to etanercept alone or in combination with methotrexate. | 2008 Jul-Aug | Scand. J. Rheumatol. | pmid:18612923 |
| Nicolin V et al. | Effect of recombinant TRAIL in a murine co-culture system of osteoclastogenesis. | 2008 Jan-Mar | Eur J Histochem | pmid:18502726 |
| Morse LR et al. | Age and motor score predict osteoprotegerin level in chronic spinal cord injury. | 2008 Jan-Mar | J Musculoskelet Neuronal Interact | pmid:18398265 |
| Uemura H et al. | Circulating osteoprotegerin is associated with age and systolic blood pressure, but not with lipid profile or fasting glucose, in postmenopausal women. | 2008 Jan-Feb | Menopause | pmid:17545921 |
| Delmas PD | Clinical potential of RANKL inhibition for the management of postmenopausal osteoporosis and other metabolic bone diseases. | 2008 Apr-Jun | J Clin Densitom | pmid:18375161 |
| Brookler K | Medical treatment of otosclerosis: rationale for use of bisphosphonates. | 2008 | Int Tinnitus J | pmid:19205157 |
| Richards JB et al. | Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. | 2008 | Lancet | pmid:18455228 |
| Elwakkad AS et al. | Fish liver oil and propolis as protective natural products against the effect of the anti-epileptic drug valproate on immunological markers of bone formation in rats. | 2008 | Epilepsy Res. | pmid:18455911 |
| Secchiero P and Zauli G | Tumor-necrosis-factor-related apoptosis-inducing ligand and the regulation of hematopoiesis. | 2008 | Curr. Opin. Hematol. | pmid:18043245 |
| Shea MK et al. | Vitamin K, circulating cytokines, and bone mineral density in older men and women. | 2008 | Am. J. Clin. Nutr. | pmid:18689371 |
| Ju JH et al. | Oral administration of type-II collagen suppresses IL-17-associated RANKL expression of CD4+ T cells in collagen-induced arthritis. | 2008 | Immunol. Lett. | pmid:18242716 |
| Seriwatanachai D et al. | Prolactin decreases the expression ratio of receptor activator of nuclear factor kappaB ligand/osteoprotegerin in human fetal osteoblast cells. | 2008 | Cell Biol. Int. | pmid:18556224 |
| Chamoux E et al. | Osteoprotegerin decreases human osteoclast apoptosis by inhibiting the TRAIL pathway. | 2008 | J. Cell. Physiol. | pmid:18338379 |
| Weissen-Plenz G et al. | Mechanisms of arterial calcification: spotlight on the inhibitors. | 2008 | Adv Clin Chem | pmid:19004192 |
| Lu HK et al. | An acute injection of Porphyromonas gingivalis lipopolysaccharide modulates the OPG/RANKL system and interleukin-6 in an ovariectomized mouse model. | 2008 | Oral Microbiol. Immunol. | pmid:18402608 |
| Schwartz Z et al. | Pulsed electromagnetic fields enhance BMP-2 dependent osteoblastic differentiation of human mesenchymal stem cells. | 2008 | J. Orthop. Res. | pmid:18404656 |